Wellington Management Group
WVE icon

Wellington Management Group’s Wave Life Sciences WVE Stock Holding History

Wellington Management Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Buy
373,794
+8,559
+2% +$112K ﹤0.01% 1501
2025
Q4 		$6.21M Sell
365,235
-64,384
-15% -$654K ﹤0.01% 1365
2025
Q3 		$3.14M Buy
429,619
+131,732
+44% +$1.07M ﹤0.01% 1534
2025
Q2 		$1.94M Sell
297,887
-1,782
-0.6% -$11.8K ﹤0.01% 1588
2025
Q1 		$2.42M Sell
299,669
-11,634
-4% -$127K ﹤0.01% 1515
2024
Q4 		$3.85M Sell
311,303
-4,199
-1% -$56K ﹤0.01% 1418
2024
Q3 		$2.59M Sell
315,502
-112,809
-26% -$674K ﹤0.01% 1491
2024
Q2 		$2.14M Buy
428,311
+29,212
+7% +$167K ﹤0.01% 1498
2024
Q1 		$2.46M Buy
399,099
+125,006
+46% +$626K ﹤0.01% 1476
2023
Q4 		$1.38M Buy
274,093
+9,208
+3% +$49.2K ﹤0.01% 1564
2023
Q3 		$1.52M Buy
264,885
+10,830
+4% +$49.4K ﹤0.01% 1524
2023
Q2 		$925K Buy
254,055
+9,057
+4% +$36.6K ﹤0.01% 1614
2023
Q1 		$1.06M Buy
244,998
+3,857
+2% +$17.7K ﹤0.01% 1643
2022
Q4 		$1.69M Buy
+241,141
New +$1.11M ﹤0.01% 1543
2021
Q2 		– Sell
-98,766
Closed -$554K – 2264
2021
Q1 		$554K Buy
98,766
+147
+0.1% +$1.41K ﹤0.01% 1835
2020
Q4 		$776K Sell
98,619
-778,173
-89% -$6.53M ﹤0.01% 1650
2020
Q3 		$7.44M Sell
876,792
-183,071
-17% -$2.01M ﹤0.01% 1170
2020
Q2 		$11M Sell
1,059,863
-1,971,431
-65% -$18.6M ﹤0.01% 1046
2020
Q1 		$28.4M Sell
3,031,294
-174,019
-5% -$1.48M 0.01% 785
2019
Q4 		$25.7M Buy
3,205,313
+118,037
+4% +$2.89M 0.01% 925
2019
Q3 		$63.4M Sell
3,087,276
-198,138
-6% -$4.54M 0.01% 664
2019
Q2 		$85.7M Buy
3,285,414
+2,484,848
+310% +$69.7M 0.02% 606
2019
Q1 		$31.1M Buy
+800,566
New +$32.5M 0.01% 885

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group's WVE Position: Q1 2026 in Review

Wellington Management Group increased its Wave Life Sciences (WVE) stake by 2.3% in Q1 2026, buying an estimated $112K and bringing the position to 373,794 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Wellington Management Group first reported a position in WVE in Q1 2019 and has held it in 23 quarters since. The position peaked at $85.7M in Q2 2019. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Wellington Management Group held 373,794 shares of Wave Life Sciences worth $2.71M as of Q1 2026.
  • Wellington Management Group bought 8,559 Wave Life Sciences shares in Q1 2026, an estimated $112K.
  • Wave Life Sciences made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1501 holding.
  • Wellington Management Group first reported a position in Wave Life Sciences in Q1 2019 and has held it in 23 quarters since.
  • Wellington Management Group's Wave Life Sciences position peaked at $85.7M in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.